Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

3(50.0%)

Early Phase 1

1(16.7%)

N/A

1(16.7%)

Phase 1

1(16.7%)

6Total

Phase 4(3)

Early Phase 1(1)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00946413Early Phase 1Completed

Application and Evaluation of Group Cognitive Intervention for Depressed Adolescents

Role: collaborator

NCT00839553Not ApplicableUnknown

Intrapleural Minocycline After Aspiration of Spontaneous Pneumothorax

Role: collaborator

NCT00837707Phase 4Unknown

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Role: collaborator

NCT00275964Completed

Development of Active Safety Surveillance System for Traditional Chinese Medicine

Role: collaborator

NCT00718250Phase 1Unknown

Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2

Role: collaborator

NCT00621998Phase 4Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Role: collaborator

NCT00459251Completed

Pharmacogenetics Study in Taiwan's Ethnic Groups

Role: collaborator

NCT00331825Phase 4Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Role: collaborator

All 8 trials loaded